Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Actavis Competing With Pharma giants for Omega Pharma Deal
Wednesday, October 22, 2014Actavis Plc ACT is among the bidders for Omega Pharma NV as the US drugmaker continues hunting for acquiring firms in the sector For Omega Pharma there are giants in line along with Actavis including Perrigo Co PRGO Sanofi SAN and Boehringer Ingelh...
Natco Pharma''s US partner gets FDA nod for wakefulness tablets
Tuesday, October 21, 2014Natco Pharmas marketing partner in US Breckenridge Pharmaceutical Inc has received a tentative approval from the US health regulator for its generic Armodafinil tablets used for improving wakefulness in adults Breckenridge Pharmaceutical Inc has re...
Taiho Oncology, Inc. receives FDA Fast Track Designation for TAS-102 as a Potential Treatment for Refractory Metastatic Colorectal Cancer
Tuesday, October 21, 2014Taiho Oncology Inc a subsidiary of Taiho Pharmaceutical Co Ltd Japan announced that the US Food and Drug Administration FDA granted Fast Track designation for TAS nonproprietary names trifluridine and tipiracil hydrochloride an oral combination antic...
Sanofi and Regeneron Pharmaceutical announce Start of Phase 3 Study of Dupilumab in patients with Atopic Dermatitis
Monday, October 20, 2014Sanofi and Regeneron Pharmaceuticals Inc today announced that the first patients have been dosed in a Phase clinical study of dupilumab an investigational therapy that blocks IL and IL signaling in adults with moderatetosevere atopic dermatitis AD t...
Actavis Confirms Generic Quillivant XR Patent Challenge
Saturday, October 18, 2014Actavis plc today confirmed that it has filed an Abbreviated New Drug Application ANDA with the US Food and Drug Administration FDA seeking approval to market Methylphenidate Hydrochloride for Extendedrelease Oral Suspension mgmL Actavis ANDA produc...
AcelRx Pharmaceuticals provides update on its Patent Portfolio for Zalviso and its Proprietary Platform Technologies
Friday, October 17, 2014AcelRx Pharmaceuticals Inc a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain today provided an update regarding its growing patent estate which...
Pharmaceutical Cannabidiol production by Insys Therapeutics granted DEA Approval
Friday, October 17, 2014Insys Therapeutics Inc has stated that its Food and Drug Administration FDA inspected and Drug Enforcement Agency DEA examined and approved facility in Round Rock Texas has got DEA approval to manufacture pharmaceutical grade Cannabidiol CBD syntheti...
Abott''s new facility launch in Gujarat today
Thursday, October 16, 2014The USheadquartered pharmaceutical and health care products company Abbott Laboratories is set to launch its first greenfield plant in India with an investment of Rs crore The facility coming up at Jhagadia in Bharuch district of Gujarat to manufac...
Akynzeo for prevention of chemotherapy-induced nausea & vomiting now approved by US FDA
Wednesday, October 15, 2014Akynzeo has been approved by the US Food and Drug Administration FDA for the prevention of acute and delayed nausea and vomiting related with initial and repeat courses of cancer chemotherapy that includes but not limited to highly emetogenic chemoth...
Bristol-Myers Squibb, Pharmacyclics pacts with Janssen to examine Opdivo and Imbruvica in non-Hodgkin lymphoma
Wednesday, October 15, 2014BristolMyers Squibb Company Pharmacyclics with Janssen Research Development will conduct a clinical trial to evaluate the safety tolerability and preliminary efficacy of BristolMyers Squibbs investigational PD immune checkpoint inhibitor Opdivo nivo...
